Favorite  |  Set Home
Products > DNA damage > HDAC > TMP269
Product name : TMP269
Item : CR1905
Price : 100mg, $695; 200mg, $1195;
contact : Send inquiry to: info@acesobio.com
Additional Information :  We offer significant discount for bulky quantity order,Please ask price and availability of other quantities
CAS : 1314890-29-3
 Enlarge Image                   Back
             [Next Product]→


Details:
 

Chemical Information

M.Wt 514.52 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C25H21F3N4O3S
CAS No 1314890-29-3
Solubility

DMSO



Biological Activity of TMP269

 

TMP269 is a novel and selective class IIa histone deacetylase inhibitor with IC50s of 126/80/36/9 nM for HDAC 4/5/7/9, respectively; 20-400 fold selectivity over class1 HDACs.
IC50 value: 126/80/36/9 nM for HDAC 4/5/7/9 [1]
Target:  class IIa HDACs
 

 

[1]. Lobera M, et al. Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group. Nat Chem Biol. 2013 May;9(5):319-25.
Abstract
In contrast to studies on class I histone deacetylase (HDAC) inhibitors, the elucidation of the molecular mechanisms and therapeutic potential of class IIa HDACs (HDAC4, HDAC5, HDAC7 and HDAC9) is impaired by the lack of potent and selective chemical probes. Here we report the discovery of inhibitors that fill this void with an unprecedented metal-binding group, trifluoromethyloxadiazole (TFMO), which circumvents the selectivity and pharmacologic liabilities of hydroxamates. We confirm direct metal binding of the TFMO through crystallographic approaches and use chemoproteomics to demonstrate the superior selectivity of the TFMO series relative to a hydroxamate-substituted analog. We further apply these tool compounds to reveal gene regulation dependent on the catalytic active site of class IIa HDACs. The discovery of these inhibitors challenges the design process for targeting metalloenzymes through a chelating metal-binding group and suggests therapeutic potential for class IIa HDAC enzyme blockers distinct in mechanism and application compared to current HDAC inhibitors.


Related Products :
Trichostatin A (TSA)
Trichostatin A (TSA)
Price: 10mg, $415; 50mg, $1395; 100mg, $1995; 200mg,$2795
Pracinostat (SB 939)
Pracinostat (SB 939)
Price: 10mg, $275; 50mg, $775; 100mg, $1295; 200mg, $2095
Mocetinostat (MGCD 0103)
Mocetinostat (MGCD 0103)
Price: 10mg, $275; 50mg, $715; 100mg, $1295; 200mg, $2295
PCI 24781 (CRA 02478)
PCI 24781 (CRA 02478)
Price: 10mg, $295; 50mg, $895; 100mg, $1295; 200mg, $2195
Panobinostat (LBH 589)
Panobinostat (LBH 589)
Price: 10mg, $90; 50mg, $265; 100mg, $375; 200mg,$595
HDAC inhibitor
HDAC inhibitor
Price: 10mg, $275; 50mg, $725; 100mg, $1295; 200mg, $2295
Tacedinaline (CI 994, PD 123654)
Tacedinaline (CI 994, PD 123654)
Price: 50mg, $195; 100mg, $395; 200mg, $695, 1g, $1295
NSC 696085 (Pyroxamide)
NSC 696085 (Pyroxamide)
Price: 10mg, $75, 50mg, $295; 100mg, $475; 200mg, $795